品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Relia Tech/Human NOGGIN/5 µg/100-260S

价格
¥1500.00
货号:100-260S
浏览量:92
品牌:Relia Tech
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat-Nr.100-260S
Size5 µg
Price75 €
SourceHEK 293 cells
Formulationlyophilized
Purity Confirmation> 95% by SDS-PAGE & HPLC analyses
Length [aa]206
Molecular Weight46 kDa
Endotoxin Levels< 0.1 ng/µg of protein (<1EU/µg)
Biological ActivityDetermined by its ability to inhibit 5.0 ng/ml of BMP-4 induced alkaline phosphatase production by ATDC chondrogenic cells. The expected ED50 for this effect is 2.0-3.0 ng/ml of Noggin.
Species ReactivityChicken, Mouse, Human
SynonymsNOG; SYM1; SYNS1
DescriptionNoggin belongs to a group of diffusible proteins which bind to ligands of the TGF-beta family and regulate their activity by inhibiting their access to signaling receptors. Noggin was originally identified as a BMP-4 antagonist whose action is critical for proper formation of the head and other dorsal structures. Consequently, Noggin has been shown to modulate the activities of other BMPs including BMP-2,-7,-13, and -14. Targeted deletion of Noggin in mice results in prenatal death and recessive phenotype displaying a severely malformed skeletal system. Conversely, transgenic mice over-expressing Noggin in mature osteoblasts display impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis. Recombinant human Noggin is a 46.2 kDa non-disulfide-linked homodimer consisting of a total of 206 amino acid residues.
Protein SequenceQHYLHIRPAP SDNLPLVDLI EHPDPIFDPK EKDLNETLLR SLLGGHYDPG FMATSPPEDR PGGGGGAAGG AEDLAELDQL LRQRPSGAMP SEIKGLEFSE GLAQGKKQRL SKKLRRKLQM WLWSQTFCPV LYAWNDLGSR FWPRYVKVGS CFSKRSCSVP EGMVCKPSKS VHLTVLRWRC QRRGGQRCGW IPIQYPIISE CKCSC
Uniprot IDQ13253
Protein RefSeqNP_005441
mRNA RefSeqNM_005450
Relia Tech类似于我们在大肠杆菌中的蛋白质表达服务,我们还提供了围绕昆虫细胞中基因和蛋白质表达(尤其是信号蛋白质)的模块化服务系统。ReliaTech的“杆状病毒表达服务(BVS)”分为一系列步骤,这些步骤可以单独执行或组合执行,因此您可以选择实际需要的步骤。这些服务旨在充分满足从基因表达到蛋白质纯化的所有特定需求-从通过重组杆状病毒构建,高滴度重组杆状病毒生产,重组蛋白批量生产以及最终蛋白质纯化的基因克隆到杆状病毒转移载体开始。所有步骤均在无血清培养基中进行,以确保安全性并产生高纯度的重组蛋白。除常规项目更新外,您还将在每个服务步骤的最后收到进度报告。我们将根据您的授权逐步指导您继续进行。